We could create synthetic lethality by adding hemin with a lower dosage of MCT1 and LDHB inhibitors, although MCT1 and LDHB inhibitors at higher concentrations are reported to suppress cancer growth [18,19,27,29]. The gene discussed is SLC16A1; the disease is cancer.